News & Updates
Filter by Specialty:
Immune-related adverse events signal better survival in non-Hodgkin lymphoma patients on ICI
The development of immune-related adverse events (irAEs) in non-Hodgkin lymphoma (NHL) patients treated with immune checkpoint inhibitors (ICI) may indicate better long-term survival, a recent study has found.
Immune-related adverse events signal better survival in non-Hodgkin lymphoma patients on ICI
11 Feb 2022
Bivalent HPV vaccine substantially reduces cervical cancer, CIN3 rates
The risk of cervical cancer and grade 3 cervical intraepithelial neoplasia (CIN3) was substantially reduced among girls who were offered the bivalent human papillomavirus (HPV) vaccine, particularly those who were offered it at age 12–13 years, according to an observational study from England.
Bivalent HPV vaccine substantially reduces cervical cancer, CIN3 rates
10 Feb 2022
Obesity, diabetes, family history up prostate cancer risk in IBD patients
A longitudinal national database study of patients with inflammatory bowel disease (IBD) has identified several risk factors for the development of prostate cancer (PC), including age, obesity, diabetes, married status, family history of PC, and African American race.
Obesity, diabetes, family history up prostate cancer risk in IBD patients
10 Feb 2022
On-body injector on par with traditional injection in preventing severe neutropaenia
Pegfilgrastim on-body injectors (OBI) are as effective as traditional injection for the prevention of severe neutropaenia (SN), neutropaenic fever, and neutropaenia in breast cancer patients, reveals a study.